Search results for "Progression"

showing 10 items of 1251 documents

Orthotopic Liver Transplantation: T-Tube or Not T-Tube? Systematic Review and Meta-Analysis of Results

2009

Background The purpose of this study was to compare outcomes after duct-to-duct anastomoses with or without biliary T-tube in orthotopic liver transplantation. Methods We pooled the outcomes of 1027 patients undergoing choledocho-choledochostomy with or without T-tube in 9 of 46 screened trials by means of fixed or random effects models. Results The "without T-tube" and "with T-tube" groups had equivalent outcomes for: anastomotic bile leaks or fistulas, choledocho-jejunostomy revisions, dilatation and stenting, hepatic artery thromboses, retransplantation, and mortality due to biliary complications. The "without T-tube" group had better outcomes when considering "fewer episodes of cholangi…

Malemedicine.medical_specialtyQuality Assurance Health Caremedicine.medical_treatmentPeritonitisGallbladder DiseasesPeritonitisLiver transplantationAnastomosisPostoperative ComplicationsOdds RatiomedicineHumansRetrospective StudiesTransplantationbusiness.industryIncidence (epidemiology)Anastomosis SurgicalRetrospective cohort studyOdds ratioRandom effects modelmedicine.diseaseLiver TransplantationSurgeryCholedochostomyMeta-analysisPractice Guidelines as TopicDisease ProgressionFemalebusinessTransplantation
researchProduct

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

2008

Aims: To gain insight in the prognosis and treatment of atrial fibrillation (AF) patients during 1-year follow-up in the Euro Heart Survey (EHS) on AF. Methods and results: The EHS enrolled 5333 AF patients in 2003-2004. One-year follow-up data were available for 80%. Of first detected AF patients, 46% did not have a recurrence during 1 year, paroxysmal AF largely remained paroxysmal AF (80%), and 30% of persistent AF progressed to permanent AF. Many treatment changes occurred since baseline. Oral anticoagulation was started in 19% and discontinued in 16% of all patients. Of patients initially on rhythm control 27% did not receive rhythm control during follow-up, whereas 15% of patients ini…

Malemedicine.medical_specialtyRate controlHeart DiseasesHeart diseasePrognosiHemorrhageRisk AssessmentAnticoagulationElectrocardiographyInternal medicineAtrial FibrillationHumansMedicineSinus rhythmProspective StudiesMortalityProspective cohort studyStrokeSurvival rateAgedProgressionmedicine.diagnostic_testbusiness.industryAnticoagulantAnticoagulantsAtrial fibrillationPrognosismedicine.diseaseManagementStrokeSurvival RateProspective StudieHeart DiseaseTreatment OutcomeHeart failureDisease ProgressionCardiologyRhythm controlFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyHumanEuropean Heart Journal
researchProduct

The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prosta…

2017

Two new drugs, the CYP17 inhibitor abiraterone acetate and the androgen receptor (AR) antagonist enzalutamide, have recently shown to prolong OS prior chemotherapy or in docetaxel treated mCRPC patients, using steroidal therapy or placebo as control group. Updated analyses underlined the role of these new agents on two prostate-specific endpoints as radiographic progression-free survival (rPFS) and time to first skeletal-related event (tSRE). On the basis of these reports, we made an indirect comparison between abiraterone and enzalutamide. We obtained a clinically but not significant difference favouring enzalutamide over abiraterone in terms of rPFS (HR 0.48, 95% CI 0.22–1.02). No signi…

Malemedicine.medical_specialtySettore MED/06 - Oncologia Medicamedicine.medical_treatmentUrologyAbiraterone AcetateBone NeoplasmsAbiraterone; Enzalutamide; mCRPC; rPFS; tSRE; Hematology; Oncology; Geriatrics and GerontologyPlaceboDisease-Free Survivallaw.invention03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicineRandomized controlled triallawNitrilesPhenylthiohydantoinEnzalutamideAndrogen Receptor AntagonistsMedicineEnzalutamideCytochrome P-450 Enzyme InhibitorsHumans030212 general & internal medicineProgression-free survivalAbirateronetSRERandomized Controlled Trials as TopicChemotherapybusiness.industryAbiraterone acetateHematologymCRPCmedicine.diseaseProstatic Neoplasms Castration-ResistantTreatment OutcomechemistryDocetaxelrPFSOncology030220 oncology & carcinogenesisBenzamidesDisease ProgressionGeriatrics and Gerontologybusinessmedicine.drugCritical reviews in oncology/hematology
researchProduct

Statin Use and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study

2018

Objective: Statins have several pleiotropic effects, but the literature regarding the possible relationship between use of statins and outcomes in knee osteoarthritis (OA) is limited. The aim of this study was to investigate whether statin use is associated with a lower risk of radiographic OA (ROA), radiographic symptomatic knee OA, and pain in North American individuals. Methods: A total of 4,448 community-dwelling adults from the Osteoarthritis Initiative were followed for 4 years. Statin use (including the time from baseline and the type of statin) was defined through self-report information and confirmed by a trained interviewer. Knee OA outcomes included incident ROA, symptomatic knee…

Malemedicine.medical_specialtyStatinmedicine.drug_classAtorvastatinPROGRESSIONOsteoarthritisLower riskTHERAPYArticleCohort Studies03 medical and health sciences0302 clinical medicineRheumatologyInternal medicinemedicineHumansEPIDEMIOLOGYRosuvastatinLongitudinal StudiesSCALEAgedddc:616030203 arthritis & rheumatologyRISKbusiness.industryIncidencenutritional and metabolic diseasesMiddle AgedOsteoarthritis Kneemedicine.diseaseDEPRESSIONRHEUMATOID-ARTHRITISKnee painRelative riskFemalemedicine.symptomHydroxymethylglutaryl-CoA Reductase Inhibitorsbusinessmedicine.drugCohort study
researchProduct

Deficit of interleukin 7 in septic patients.

2014

We recently demonstrated an overall decrease of all αβ and specially γδ T cell subsets in patients with sepsis compared with healthy subjects. IL-7 is a crucial factor for development of γδ T cells and survival in sepsis but its association with sepsis severity, evolution of organ failure and death still has not been investigated. Sera from 78 patients who met criteria for sepsis were analyzed vs control group. Septic patients showed the lowest levels of IL-7. Patients with severe sepsis reached levels of IL-7 higher than those observed in the groups of uncomplicated sepsis and septic shock. The frequency of γδ T cells at admission was lower in septic patients vs control group. At the time …

Malemedicine.medical_specialtyT cellT-LymphocytesImmunologyGastroenterologySepsisInternal medicineSepsismedicineImmunology and AllergyHumansIn patientLymphocyte CountSevere sepsisAgedPharmacologyAged 80 and overSeptic shockbusiness.industryInterleukin-7Healthy subjectsInterleukinReceptors Antigen T-Cell gamma-deltaMiddle Agedmedicine.diseasemedicine.anatomical_structureSpainCase-Control StudiesImmunologyDisease ProgressionFemalebusinessInternational immunopharmacology
researchProduct

Cognitive deficits associated with acquired amusia after stroke: A neuropsychological follow-up study

2009

Recent evidence on amusia suggests that our ability to perceive music might be based on the same neural resources that underlie other higher cognitive functions, such as speech perception and spatial processing. We studied the neural correlates of acquired amusia by performing extensive neuropsychological assessments on 53 stroke patients with a left or right hemisphere middle cerebral artery (MCA) stroke 1 week, 3 months, and 6 months after the stroke. In addition, structural magnetic resonance imaging (MRI) was performed on all patients 1 week and 6 months post-stroke. Based on their performance on a shortened version of the Montreal Battery of Evaluation of Amusia (MBEA), the patients we…

Malemedicine.medical_specialtyTime FactorsCognitive NeuroscienceExperimental and Cognitive PsychologyNeuropsychological TestsAudiologyAmusiaVerbal learningFunctional Laterality050105 experimental psychology03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinemedicineHumans0501 psychology and cognitive sciencesAuditory Diseases CentralAgedRetrospective StudiesAnalysis of VarianceWorking memory05 social sciencesCognitive disorderNeuropsychologyCognitive flexibilityCognitionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingStrokeAcoustic StimulationVisuospatial perceptionDisease ProgressionFemaleCognition DisordersPsychologyMusic030217 neurology & neurosurgeryFollow-Up StudiesCognitive psychologyNeuropsychologia
researchProduct

Progression of aortic pulse wave velocity in patients with chronic kidney disease.

2013

Aortic pulse wave velocity (aPWV) is elevated in patients with chronic kidney disease (CKD) and predicts cardiovascular risk. However, the natural progression of arterial stiffness in these patients remains uncertain. Therefore, the main aim of this study was to investigate the development of aPWV and to identify potential factors associated with its progression. aPWV measurement was carried out in 70 CKD patients at baseline and after 12 months. Correlations to several variables, in particular annual glomerular filtration rate reduction and diabetes mellitus, were studied. In the cohort, aPWV significantly increased in 1 year by 1.1 m/s (P<.01). Dividing the group into patients with stable…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismRenal functionBlood PressurePulse Wave AnalysisCohort StudiesVascular StiffnessRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansIn patientLongitudinal StudiesProspective StudiesRenal Insufficiency ChronicLetters to the EditorPulse wave velocityAortaAgedbusiness.industryMiddle Agedmedicine.diseaseddc:EndocrinologyBlood pressureCardiovascular DiseasesCohortArterial stiffnessCardiologyDisease ProgressionFemaleCardiology and Cardiovascular MedicinebusinessKidney diseaseGlomerular Filtration RateJournal of clinical hypertension (Greenwich, Conn.)
researchProduct

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a m…

2006

ABSTRACT Background: Combinations of gemcitabine–oxaliplatin, gemcitabine–5-fluorouracil (5-FU) and 5-FU–oxaliplatin have synergistic activity and nonoverlapping adverse effect profiles. This trial assessed efficacy and safety of the triple combination gemcitabine–oxaliplatin and infusional 5-FU in patients with locally advanced (n = 11) or metastatic (n = 32) pancreatic adenocarcinoma. Patients and methods: A total of 43 eligible patients were treated with intravenous infusions of gemcitabine (900 mg/m2 over 30 min), followed by oxaliplatin (65 mg/m2 over 2 h) and 5-FU (1500 mg/m2 over 24 h) on days 1 and 8 of a 21-day cycle. Results: Among all 43 patients, the tumor response rate was 19% …

Malemedicine.medical_specialtyTime FactorsOrganoplatinum Compoundsmedicine.medical_treatmentPhases of clinical researchAdenocarcinomaDeoxycytidineGastroenterologyDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLost to follow-upInfusions IntravenousAgedChemotherapyCardiotoxicitybusiness.industryCombination chemotherapyHematologyMiddle AgedGemcitabineChemotherapy regimenGemcitabineSurgeryOxaliplatinOxaliplatinPancreatic NeoplasmsSurvival RateTreatment OutcomeOncologyDisease ProgressionQuality of LifeFemaleFluorouracilbusinessmedicine.drugAnnals of Oncology
researchProduct

Impact of Accessory Renal Artery Coverage on Renal Function during Endovascular Aortic Aneurysm Repair.

2021

Background Long-term outcomes of accessory renal artery (ARA) coverage after endovascular aneurysm repair (EVAR) are unknown. We analyzed the impact of ARA coverage on renal function long-term. Methods This retrospective, monocentric study included patients treated by EVAR between 2008 and 2016. Patients with at least one ARA covered with EVAR (ARA group) were compared with patients with no covered ARA (control group). Renal function was determined by estimating the glomerular filtration rate (eGFR) and graded according to chronic kidney disease (CKD) classification stages. Results A total of 184 patients were included (ARA group, n = 25; control group, n = 159). Renal risk factors were sim…

Malemedicine.medical_specialtyTime FactorsRenal infarctionmedicine.medical_treatmentUrologyRenal function030204 cardiovascular system & hematologyKidneyEndovascular aneurysm repair030218 nuclear medicine & medical imagingAccessory renal artery03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicineRenal ArterymedicineHumansStage (cooking)Renal Insufficiency ChronicSuprarenal fixationAgedRetrospective StudiesAged 80 and overAortic aneurysm repairbusiness.industryEndovascular Proceduresfood and beveragesGeneral Medicinebiochemical phenomena metabolism and nutritionmedicine.diseaseAortic AneurysmBlood Vessel Prosthesiscarbohydrates (lipids)Treatment OutcomeDisease ProgressionSurgeryFemaleCardiology and Cardiovascular MedicinebusinessKidney diseaseGlomerular Filtration RateAnnals of vascular surgery
researchProduct

Prognosis in patients with microvascular angina: A clinical follow-up

2019

Malemedicine.medical_specialtyTime Factorschest painMEDLINEmicrocirculationChest painMicrocirculationText miningRecurrenceRisk FactorsCause of DeathInternal medicineHumansMedicineIn patientAgedCause of deathbusiness.industryDisease progressionMicrovascular anginaCardiovascular AgentsRecovery of FunctionGeneral MedicineMiddle AgedTreatment Outcomemicrovascular anginaDisease ProgressionoutcomeFemalemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct